Literature DB >> 19605

Hallucinogen binding to dopamine/neuroleptic receptors.

P M Whitaker, P Seeman.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 19605     DOI: 10.1111/j.2042-7158.1977.tb11381.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  7 in total

1.  High-affinity 3H-serotonin binding to caudate: inhibition by hallucinogens and serotoninergic drugs.

Authors:  P M Whitaker; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

2.  Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine.

Authors:  J K Staley; Q Ouyang; J Pablo; W L Hearn; D D Flynn; R B Rothman; K C Rice; D C Mash
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

3.  Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.

Authors:  J Koerner; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Haloperidol and insulin release.

Authors:  F Lechin; B van der Dijs
Journal:  Diabetologia       Date:  1981       Impact factor: 10.122

5.  Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.

Authors:  P A Pierce; S J Peroutka
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Behavioural changes induced by N,N-dimethyl-tryptamine in rodents.

Authors:  P Jenner; C D Marsden; C M Thanki
Journal:  Br J Pharmacol       Date:  1980-05       Impact factor: 8.739

7.  Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity.

Authors:  P M Sweetnam; J Lancaster; A Snowman; J L Collins; S Perschke; C Bauer; J Ferkany
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.